Takeda, TWi have ‘no right’ to discovery stay in pharma suit, US judge says
Takeda Pharmaceuticals and TWi Pharmaceuticals won’t be able to pause burden-free, relevant document discovery requests from grocers bringing a pay-for-delay lawsuit involving the acid reflux treatment Dexilant and its generic equivalents,...To view the full article, register now.
Already a subscriber? Click here to view full article